Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1996-07-25
1999-01-19
Stucker, Jeffrey
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 234, 536 243, 536 2433, 536 245, 530350, 5303883, 4241591, 4241471, 4241921, 4242291, 435 6, 435 691, 435 693, 4352351, 435325, 4352521, 4353201, A61K 39245, C07H 2104, C07K 1403, C12N 1538
Patent
active
058615008
ABSTRACT:
This invention provides an isolated DNA molecule which encodes interleukin 6 (IL-6) of Kaposi's sarcoma-associated herpesvirus. Antisense oligonucleotide molecules are also provided.
REFERENCES:
patent: 5188828 (1993-02-01), Goldberg et al.
patent: 5217881 (1993-06-01), Park
patent: 5264209 (1993-11-01), Mikayama et al.
patent: 5300292 (1994-04-01), Ulich
patent: 5338833 (1994-08-01), Fowlkes
patent: 5338834 (1994-08-01), Williams
patent: 5359034 (1994-10-01), Skelly et al.
patent: 5376368 (1994-12-01), Ulich
patent: 5470824 (1995-11-01), Miles et al.
Armstrong et al. (1994) Melanoma-derived interleukin 6 inhibits in vivo melanoma growth, J. Invest. Dermatol 102, 278-284 (Exhibit 2).
Burger et al. (1994) Interleukin-6 production in B-cell neoplasias and Castleman's disease: evidence for an additional paracrine loop, Annals Hematol, 69, 25-31 (Exhibit 3).
Emilie et al. (1992) Production of interleukin-6 in high grade B lymphomas, Curr. Top. Microbiol Immunol 182, 349-355 (Exhibit 4).
Evans et al. (1992) Tumor cell IL-6 gene expression is regulated by IL-lalpha/beta and TNFalpha: proposed feedback mechanisms induced by the interaction of tumor cells and macrophages, J. Leukocyte Biol. 52, 463-468 (Exhibit 5).
Karp and Broder (1991) Acquired immunodeficiency syndrome and non-Hodgkin's lymphomas, Cancer Research 51, 4743-4756 (Exhibit 6).
Klein (1995) Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma, Semin. Hematol. 32, 4-19 (Exhibit 7).
Lotz (1993) Interleukin-6, Cancer Invest. 11, 732-742 (Exhibit 8).
Rifas et al. (1995) Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids, Endocrinology 136, 4056-4067 (Exhibit 9).
Tan et al. (1990) Expression of the interleukin 6 gene in rheumatoid synovial fibroblasts, J. Rheumatol 17, 1608-1612 (Exhibit 10).
Yuan et al. (1994) The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements, Mol. Cell Biol. 14, 1657-1668 (Exhibit 11).
Albrecht et al. (1992) Primary structure of the herpesvirus saimiri genome, J Virol 66, 5407-5058 (Exhibit 2).
Almeida et al. (1994) Human cytomegalovirus alters interleukin-6 production by endothelial cells, Blood 83, 370-376 (Exhibit 3).
Birkenbach et al. (1993) Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors, J Virol 67, 2209 (Exhibit 4).
Tur and Brenner (Mar. 1996) Treatment of Kaposi's sarcoma, Arch Dermatol 132, 327-331 (Exhibit 5).
Chee et al. (1995) Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169, Curr Top Microbiol Immunol 154, 125-169 (Exhibit 6).
Cleary et al. (1986) Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation, Cell 47, 19-28 (Exhibit 7).
Cohen et al. (1996) Interleukin 6 induces the expression of vascular endothelial growth factor, J Biol Chem 271, 736-741 (Exhibit 8).
Ensoli et al. (1992) Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma, Immunol Reviews, 127, 147-154 (Exhibit 9).
Finke et al. (1992) Expression bcl-2 in burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes, Blood 80, 459-469 (Exhibit 10).
Finke et al. (1994) BCL-2 induction is part of the strategy of Epstein-Barr virus, Leuk Lymphoma 12, 413-419 (Exhibit 11).
Gao and Murphy (1994) Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor, J Biol Chem 269, 28539-28542 (Exhibit 12).
Holzinger et al. (1993) Effects of interleukin-1, -2, -4, -6, interferon-gamma and granulocyte/macrophage colony stimulating factor on human vascular endothelial cells, Immunol Lett 35, 109-117 (Exhibit 13).
Jones et al. (1995) Infection of human endothelial cells with Epstein-Barr virus, J Exp Med 182, 1213-1221 (Exhibit 14).
Lafeuillade et al. (1996) IL-6 and b-FGF overproductions precede development of AIDS-associated Kaposi's sarcoma, J AIDS Hum Retrovirol 12, 95 (Exhibit 15).
Larcher et al. (1995) Expression of Epstein-Barr virus nuclear antigen-2 (EBNA2) induces CD21/CR2 ib B and T cell lines and shedding of soluble CD21, Eur J Immunol 25, 1713-1719 (Exhibit 16).
Lichtenstein et al. (1995) Interleukin-6 inhibits apoptosis of malignant plasma cells, Cellular Immunology 162, 248-255 (Exhibit 17).
Massung et al. (1994) Analysis of the complete genome of smallpox variola major virus strain bangladesh-1975, Virol 201, 215-240 (Exhibit 18).
Palmero et al. (1993) Cyclins D1 and D2 are differentially expressed in human B-lypoid cell lines, Oncogene 8, 1049 (Exhibit 19).
Scala et al. (1990) Expression of an exogenous interleukin 6 gene in human Epstein Barr virus B cells confers growth advantage and in vivo tumorigencity, J Exp Med 172, 61-68 (Exhibit 20).
Renne et al. (Mar. 1996) Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture, Nat Med 2, 342-346 (Exhibit 21).
Shen and Shenk (1995) Viruses and apoptosis, Curr Opin Genet Dev 5, 105-111 (Exhibit 22).
Weiss (Mar. 1996) Human herpesvirus 8 in lymphoma and Kaposi's sarcoma: now the virus can be propagated, Nat Med 2, 277-278 (Exhibit 23).
Tosato et al. (1990) Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells, J Virol 64, 3033-3041 (Exhibit 24); and.
Zhong et al (1996) Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesviurs 8) genes in Kaposi sarcoma, Proc Natl Acad Sci USA 93, 6641-6646 (Exhibit 25).
Chang et al. Science vol. 266, 16 Dec. 1994, pp. 1865-1869.
Bohenzky Roy A.
Chang Yuan
Edelman Isidore S.
Moore Patrick S.
Russo James J.
Bui Phuong T.
Stucker Jeffrey
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1247655